Adolescent and Adult Asthma in NZ, Understanding the Guidelines - On Demand
- $0.00 incl. GST for members
- $100.00 incl. GST for non-members
About the product
This course is provided by College Education and Training, a business unit of Pharmaceutical Society of New Zealand Inc.
In this webinar, we will discuss the Asthma and Respiratory Foundation of New Zealand adolescent and adult asthma guidelines which were published in 2020. The guidelines provide simple, practical and evidence-based recommendations for the diagnosis, assessment and management of asthma in adolescents and adults (aged 12 and over) in a quick reference format. The intended participants for this webinar are health professionals responsible for delivering asthma care in the community and hospital settings, and those responsible for the training of such health professionals.
Thanks to Astra Zeneca's generous sponsorship of this course, we are able to offer it free of charge for our members. However, all course content has been developed independently of their contribution.
CNZM, DSc(Otago), DM(Southampton), MBChB, FRCP(London), FRACP, FAAAAI, FFOM(Hon), FAPSR(New Zealand), FERS, FRSNZ
Richard Beasley is a physician at Wellington Regional Hospital, Director of the Medical Research Institute of New Zealand, and Professor of Medicine at Victoria University of Wellington. He is an Adjunct Professor at the University of Otago and Visiting Professor, University of Southampton, United Kingdom. He was previously the Deputy Chair of the Health Research Council of New Zealand and is currently Chair of the New Zealand adolescent and adult asthma guidelines. His research interests in respiratory medicine are primarily in the fields of epidemiology and clinical management. He has over 700 publications, and a Google Scholar H-index of 103.
Upon successful completion of this course, you will be able to;
- Describe the NZ Adolescent and Adult Asthma Guidelines, including the new recommendations in the 2020 update
- Recognise the characteristic pattern of signs and symptoms of asthma
- Explain the role pharmacists play in managing patients through treatment changes and identify patients in need of treatment review
- Describe the management of asthma in adolescents or adults in New Zealand, including the use of anti-inflammatory reliever ‘ or ‘ AIR’ therapy
- Identify barriers to effective asthma management in New Zealand and discuss strategies to reduce these